FFEA.F · Faes Farma, S.A

-

Please sign in to comment on FFEA.F

1 Comment

Admin

4 years, 1 month ago

Faes Farma, S.A is currently in a long term downtrend where the price is trading 3.3% below its 200 day moving average.

From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.8.

Faes Farma, S.A's total revenue rose by 0.1% to $90M since the same quarter in the previous year.

Its net income has increased by 58.6% to $18M since the same quarter in the previous year.

Finally, its free cash flow fell by 44.6% to $5M since the same quarter in the previous year.

Based on the above factors, Faes Farma, S.A gets an overall score of 3/5.

ISIN	ES0134950F36
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
Exchange	F
CurrencyCode	EUR

Dividend Yield	1.9%
Market Cap	1B
PE Ratio	11.78
Target Price	None
Beta	0.31

ABOUT

Faes Farma, S.A

Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials worldwide. It operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. It offers products for various therapeutic areas. The company also provides animal nutrition and health products. Faes Farma, S.A. was incorporated in 1933 and is headquartered in Leioa, Spain.

FFEA.F · Faes Farma, S.A

-

Faes Farma, S.A

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Faes Farma, S.A using a moving average strategy